Meet team IOLCP at

CPHI
Frankfurt 2022

CPHI Frankfurt 2022

calendar
1st - 3rd November
location
The Messe Frankfurt, Germany,
Hall Number-H12.0 | Stand:120C50
Reserve a slot
Contact Us

About IOLCP

about-iolcp

We develop and manufacture APIs for major pharma companies around the world. Today, by leveraging our substantial production capabilities, we are now able to overcome cost and scale challenges.

APIs from our portfolio include Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant properties. We are the only backward integrated firm producing all Intermediates and Key Starting Materials (KSMs) of ibuprofen.

IOLCP strives to achieve excellence at every stage of the value chain. Our unwavering commitment to excellence in operations, innovation, quality, and customer service has helped us become a market leader.

Know More

About CPHI

We develop and manufacture APIs for major pharma companies around the world. Today, by leveraging our substantial production capabilities, we are now able to overcome cost and scale challenges.

APIs from our portfolio include Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant properties. We are the only backward integrated firm producing all Intermediates and Key Starting Materials (KSMs) of ibuprofen.

IOLCP strives to achieve excellence at every stage of the value chain. Our unwavering commitment to excellence in operations, innovation, quality, and customer service has helped us become a market leader.

about-cphi

Who we are

Founded 30 years ago, IOL Chemicals and Pharmaceuticals Limited is one of the most consistent pharma companies in delivering innovation-driven solutions to market needs.

cphi-year

30+
Years

cphi-experts

50+
R&D experts

cphi-workspace

2000+
Workforce

Our Vison

our-vision-cphi

To be amongst the most admired companies in APIs, Intermediaries, and Specialty Chemicals globally.

        Know More

Our Mission

our-mission-cphi

To provide top quality products in APIs, Intermediates and Specialty Chemicals through continuous innovation and cutting-edge technology, with due regards to safety and environment.

Know More

Our Values

our-values-cphi

We at IOL, believe values bring character to any organization that help leaders to guide teams for a culture of excellence through continuous improvements.


Know More

Our Portfolio

Ibuprofen

Therapeutic Category: NSAID

CAS No: 15687-27-1

Metformin HCL

Therapeutic Category: Anti-Diabetic

CAS No: 1115-70-4

Clopidogrel Bisulphate (Form II)

Therapeutic Category: Anti-Platelet

CAS No: 120202-66-6

Pantoprazole Sodium

Therapeutic Category: Proton Pump Inhibitor

CAS No: 164579-32-2

Fenofibrate (Micronised)

Therapeutic Category: Anti-Cholesterol

CAS No: 49562-28-96

Gabapentin

Therapeutic Category: Anti-Convulsant

CAS No: 60142-96-3

Lamotrigine

Therapeutic Category: Anti-Convulsant

CAS No: 84057-84-1

Ursodeoxycholic Acid

Therapeutic Category: Anti-Cholelithic

CAS No: 128-13-2

Losartan Potassium

Therapeutic Category: Anti-Hypertensive

CAS No: 124750-99-8

Levetiracetam

Therapeutic Category: Anti-Epileptic

CAS No: 102767-28-2

Paracetamol

Therapeutic Category: Analgesic & Antipyretic

CAS No: 103-90-2

Ibuprofen Lysinate

Therapeutic Category: NSAID

CAS No: 57469-76-8

Ibuprofen Sodium

Therapeutic Category: NSAID

CAS No: 31121-93-4

Dex-Ibuprofen

Therapeutic Category: NSAID

CAS No: 51146-56-6

Our Milestones

  1. 1986

    1986
    IOL Chemicals and Pharmaceutical Limited was incorporated in 1986 with Acetic Acid Plant

  2. 1996

    1996
    Commencement of Ethyl Acetate Plant

  3. 1999

    1999
    Commencement of Acetic Anhydride Plant

  4. 2000

    2000
    Commencement of Ibuprofen Unit-1

  5. 2007

    2007
    Established Unit-1 dedicated for Ibuprofen Established Multi fuel captive co-generation power plant of 4MW capacity

  6. 2009

    2009
    Commencement of Iso Butyl Benezene, Mono Chloro Acetic Acid and Acetyl Chloride Plant leading to backward integration to Ibuprofen

  1. 2016

    2016
    Commencement of Unit-3 for new product launches

  2. 2015

    2015
    USFDA EIR for Ibuprofen

  3. 2013

    2013
    Received EUGMP certification

  4. 2012

    2012
    Commencement of Unit-2 for Multi product

  5. 2010

    2010
    IOL gets listed on the National Stock Exchange (NSE) Established Multi fuel captive co-generation power plant of 13MW capacity 2012

  1. 2018

    2018
    Established Unit-4 dedicated for Metformin Hydrochloride Unit-5 dedicated for Clopidogrel Bisulfate Form II & Fenofibrate

  2. 2019

    2019
    Established Unit-6 dedicated for Pantoprazole Sodium

  3. 2020

    2020
    Established Unit-7 dedicated for Metformin

  4. 2021

    2021
    Established Unit-8 for Multi Products

  5. 2022

    2022
    Began commercial production of Paracetamol

Market Presence

map-location